| Serial Number | 88833703 |
| Word Mark | ONOGATE |
| Filing Date | Friday, March 13, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, December 1, 2020 |
| Registration Number | 6209391 |
| Registration Date | Tuesday, December 1, 2020 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 15, 2020 |
| Description of Mark | The mark consists of three trapezoids in which the top trapezoid is in dark orange with the white non-Latin characters, the middle trapezoid is in orange with white wording "ONOGATE" and the bottom trapezoid is in red with the white wording "CAPSULE". |
| Goods and Services | Amino acid preparations for medical purposes; Amino acids for medical purposes; Dietary supplements; Dietary supplements also containing herbal extracts; Dietary supplements also containing amino acids; Dietary supplements also containing collagen; Dietary supplements also containing iron; Dietary supplements also containing calcium; Dietary supplements also containing magnesium; Dietary supplements also containing minerals and trace elements; Dietary supplements also containing vitamins; Dietary supplements for human consumption; Dietary supplements with a cosmetic effect; Dietary and nutritional supplements containing amino acids; Dietary and nutritional supplements containing collagen; Herbal extracts for medical purposes; Herbal supplements; Herbal supplements for sleeping problems; Herbal tinctures for medical purposes; Herbs for medicinal purposes; Nutritional supplements; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of spondyloarthropathy; Pharmaceutical preparations, namely, analgesic properties; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of joint disease; Vitamin and mineral preparations for medical use; Vitamin and mineral supplements; Albumin dietary supplements; Allergy capsules; Anti-inflammatories; Anti-inflammatory preparations; Dietary and nutritional supplements; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Ethers for pharmaceutical purposes; Fish meal for pharmaceutical purposes; Herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; Liquid herbal supplements; Medicinal herb extracts; Medicinal herbal extracts for medical purposes; Medicinal herbal preparations; Medicinal herbs; Medicinal herbs in dried or preserved form; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Mineral nutritional supplements; Natural dietary supplements; Natural herbal supplements; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for treatment of bone disease; Nutraceuticals for use as a dietary supplement for treatment of joint health; Nutraceuticals for use as a dietary supplement for treatment of rheumatoid arthritis; Nutraceuticals for use as a dietary supplement for treatment of spondyloarthropathy; Plant extracts for pharmaceutical purposes; Plant extracts for medical, veterinary and pharmaceutical purposes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; Therapeutic pharmaceutical for the treatment of rheumatoid arthritis; Therapeutic pharmaceutical for the treatment of skeletal diseases and disorders; Therapeutic pharmaceutical for the treatment of spondyloarthropathy |
| Pseudo Mark | ON GATE |
| Indication of Colors claimed | The color(s) orange, dark orange, red, and white are claimed as a feature of the mark. |
| Transliteration Statement | The non-Latin characters in the mark transliterate to "tian ran wu" and this means "natural product" in English. |
| Disclaimer with Predetermined Text | "CAPSULE" AND THE NON-LATIN CHARACTERS THAT TRANSLITERATE TO "TIAN RAN WU" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 12, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | Friday, November 30, 2018 |
| First Use In Commerce Date | Friday, November 30, 2018 |
| Party Name | PT. Natura Nuswantara Nirmala |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Pondok Pucung Pondock 15429 ID |
| Party Name | PT. Natura Nuswantara Nirmala |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Pondok Pucung Pondock 15429 ID |
| Party Name | PT. Natura Nuswantara Nirmala |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Pondok Pucung Pondock 15429 ID |
| Event Date | Event Description |
| Tuesday, December 1, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, September 15, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 15, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 26, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, August 7, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, August 7, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Friday, August 7, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, August 7, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Friday, August 7, 2020 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, July 24, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Friday, July 24, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, July 24, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Friday, July 24, 2020 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, July 8, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, July 8, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, July 2, 2020 | ASSIGNED TO LIE |
| Monday, June 22, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, June 12, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, June 12, 2020 | NON-FINAL ACTION E-MAILED |
| Friday, June 12, 2020 | NON-FINAL ACTION WRITTEN |
| Friday, June 12, 2020 | REMOVED FROM TEAS PLUS |
| Friday, June 5, 2020 | ASSIGNED TO EXAMINER |
| Friday, March 20, 2020 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, March 19, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 17, 2020 | NEW APPLICATION ENTERED |